Schafer Cullen Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Schafer Cullen Capital Management's AMGN Position: Q1 2021 in Review
Schafer Cullen Capital Management sold out of Amgen (AMGN) in Q1 2021, closing a stake of 2,860 shares — an estimated $658K sold.
Schafer Cullen Capital Management first reported a position in AMGN in Q1 2017 and held it in 16 quarters. The position peaked at $727K in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.
- Schafer Cullen Capital Management reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
- Schafer Cullen Capital Management sold 2,860 Amgen shares in Q1 2021, an estimated $658K.
- Schafer Cullen Capital Management first reported a position in Amgen in Q1 2017 and held it in 16 quarters.
- Schafer Cullen Capital Management's Amgen position peaked at $727K in Q3 2020.
- 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.
Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.